DnaNudge
PrivateLast Round
Series A
Aug 31, 2021
Total Funding Raised
$60M
Company Overview
DnaNudge operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series A round in August 2021.
DnaNudge is a health technology company that develops wearable devices and diagnostic platforms that use consumer DNA and lifestyle factors to provide personalized health and nutrition recommendations.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine, Personalization
Business Model
B2C
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DnaNudge Comparables
Compare DnaNudge with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prenetics | 77% | |
| QuantuMDx | 74% | |
| Abbott Laboratories | 73% |
For institutional investors. Book with your work email.
DnaNudge Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DnaNudge Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sumitomo Mitsui Trust Bank | Series A |
| Julius Baer | Series A |
| Ventura Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
Monthly visitors increased 42% MoM.
- Aug 31, 2021
$60M round led by Ventura Capital
For institutional investors. Book with your work email.
DnaNudge Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DnaNudge's valuation, stock price, and market status.
Is DnaNudge a public or private company?
DnaNudge is a private company.
What is the current stock price of DnaNudge?
DnaNudge is a private company, so its shares have no public market price. Caplight tracks DnaNudge's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DnaNudge worth (valuation)?
Valuation information for DnaNudge is not publicly available.
Can I buy DnaNudge stock?
DnaNudge shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DnaNudge's last funding round?
DnaNudge's most recent funding round was Series A on August 31, 2021.
Who are the main investors in DnaNudge?
Key investors in DnaNudge include Ventura Capital.
Will DnaNudge IPO soon?
No public IPO plans have been announced for DnaNudge.
How can I track DnaNudge secondary market activity?
Caplight tracks bids, offers, and trades in DnaNudge's shares on secondary markets.